Deaths from breast cancer fall dramatically in UK and USBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7247.1428/a (Published 27 May 2000) Cite this as: BMJ 2000;320:1428
- Zosia Kmietowicz
Deaths from breast cancer in Britain have fallen by nearly a third in the past 10 years thanks largely to wider and more prolonged use of the antioestrogen drug tamoxifen. A similar but smaller decline in deaths from the disease—about 25%—has been observed among US women since 1990.
“This is the best decrease in national death rates that has ever been seen with any common cancer that has been produced by treatment,” commented Professor Sir Richard Peto from the Imperial Cancer Research Fund's cancer trials …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial